Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial
For researchers running microdose protocols or titrating doses in very small increments, this level of precision is valuable
Please obtain the verified products through legal channels and avoid mixing them with unverified drugs
the peptide has the potential to induce a wide range of responses from growth stimulation to toxic cell differentiation
It is a small-molecule NNMT inhibitor
It reflects industry-informed predictions only
US$ 29.63
US$ 28.21
US$ 20.83
US$ 29.16
US$ 21.39
US$ 21.08
US$ 28.88
